Skip to main content
. 2020 Jun 25;9(6):359. doi: 10.3390/antibiotics9060359

Table 6.

Assay of DLFX in marketed tablets and SLNs formulation by the green RP-HPTLC and NP-HPTLC methods (n =3).

Samples Theoretical Content (mg) Content Found (ng) ± SD Assay (%)
Green RP-HPTLC method
Marketed tablets 50 49.1 ± 1.0 98.2
SLNs 50 50.5 ± 1.1 101.0
NP-HPTLC method
Marketed tablets 50 47.2 ± 1.2 94.4
SLNs 50 47.5 ± 1.3 95.0